Diclofenac gel in the treatment of actinic keratoses

References

• SalascheSJEpidemiology of actinic keratoses and squamous cell carcinomaJ Am Acad Dermatol2000421 Pt 24710607349
   PubMed Web of Science ®Google Scholar
• FeldmanFleischerABJrMcConnellCMost common dermatologic problems identified by internists; 1990–1994Arch Intern Med199815877267309554678
   PubMedGoogle Scholar
• FrostCAGreenACEpidemiology of solar keratosesBr J Dermatol199413144554647947197
   PubMed Web of Science ®Google Scholar
• MoyRLClinical presentation of actinic keratoses and squamous cell carcinomaJ Am Acad Dermatol2000421 Pt 281010607350
   PubMed Web of Science ®Google Scholar
• AckermanABMonesJMSolar (actinic) keratosis is squamous cell carcinomaBr J Dermatol2006155192216792746
   PubMed Web of Science ®Google Scholar
• QuatresoozPCPierard-FranchimontCPauquetPCrossroads between actinic keratosis and squamous cell carcinoma, and novel pharmacological issuesEur J Dermatol200818161018086582
   PubMed Web of Science ®Google Scholar
• OppelTKortingHCActinic keratosis: The key event in the evolution from photoaged skin to squamous cell carcinoma. Therapy based on pathogenetic and clinical aspectsSkin Pharmacol Physiol2004172677614976383
   PubMed Web of Science ®Google Scholar
• SchwartzRAThe actinic keratosis. A perspective and updateDermatol Surg19972311100910199391557
   PubMed Web of Science ®Google Scholar
• MarksRRennieGSelwoodTSMalignant transformation of solar keratoses to squamous cell carcinomaLancet1988185897957972895318
   PubMed Web of Science ®Google Scholar
• GlogauRGThe risk of progression to invasive diseaseJ Am Acad Dermatol2000421 Pt 2232410607353
   PubMed Web of Science ®Google Scholar
• CallenJPBickersDRMoyRLActinic keratosesJ Am Acad Dermatol19973646506539092763
   PubMed Web of Science ®Google Scholar
• DinehartSMThe treatment of actinic keratosesJ Am Acad Dermatol2000421 Pt 2252810607354
   PubMed Web of Science ®Google Scholar
• StockflethEFerrandizCGrobJJDevelopment of a treatment algorithm for actinic keratoses: A European consensusEur J Dermatol200818665165918955209
   PubMed Web of Science ®Google Scholar
• VatveMOrtonneJPBirch-MachinMAGuptaGManagement of field change in actinic keratosisBr J Dermatol2007157Suppl 2212418067627
   PubMed Web of Science ®Google Scholar
• LovenKSteinLFurstKLevySEvaluation of the efficacy and tolerability of 0.5% fluorouracil cream and 5% fluorouracil cream applied to each side of the face in patients with actinic keratosisClin Ther2002246990100012117087
   PubMed Web of Science ®Google Scholar
• JorizzoJLCarneyPSKoWTRobinsPWeinkleSHWerschlerWPFluorouracil 5% and 0.5% creams for the treatment of actinic keratosis: Equivalent efficacy with a lower concentration and more convenient dosing scheduleCutis2004746 Suppl182315666898
   PubMed Web of Science ®Google Scholar
• Aldara [Package insert]Bristol, TNGraceway Pharmaceuticals2009
   Google Scholar
• QuistSRGollnickHPImiquimod 3.75% cream (Zyclara) for the treatment of actinic keratosesExpert Opin Pharmacother201112345146121254950
   PubMed Web of Science ®Google Scholar
• FecklerLStockflethEBraunFKEnhanced death ligand-induced apoptosis in cutaneous SCC cells by treatment with diclofenac/ hyaluronic acid correlates with downregulation of c-FLIPJ Invest Dermatol201013082098210920237495
   PubMed Web of Science ®Google Scholar
• WolfJETaylorJRTschenEKangSTopical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratosesInt J Dermatol2001401170971311737438
   PubMed Web of Science ®Google Scholar
• PfleugfelderAWelterAKLeiterUOpen label randomized study Comparing 3 months vs 6 months treatment of actinic keratoses with 3% Diclofenac in 2.5% hyaluronic gel: a trial of the German Dermatologic Cooperative Oncology GroupJ Eur Acad Dermatol Venereol201131810.1111/j.1468-3083.2011.04005.x. [Epub ahead of print]
   Web of Science ®Google Scholar
• NelsonCRigelDLong-term follow-up of diclofenac sodium 3% in 2.5% hyaluronic acid gel for actinic keratosis: 1-year evaluationJ Clin Aesthet Dermatol200927202520729966
   PubMedGoogle Scholar
• NelsonCGSpencerJNelsonCGJrA single-arm, open-label efficacy and tolerability study of diclofenac sodium 3% gel for the treatment of actinic keratosis of the upper and lower lipJ Drugs Dermatol20076771271717763595
   PubMedGoogle Scholar
• UlrichCJohannsenARöwert-HuberJUlrichMSterryWStockflethEResults of a randomized, placebo-controlled safety and efficacy study of topical 3% diclofenac gel in organ transplant patients with multiple actinic keratosesEur J Dermatol201020448248820507841
   PubMed Web of Science ®Google Scholar
• MontoroJRodriguezMDiazMBertomeuFPhotoallergic contact dermatitis due to diclofenacContact Dermatitis200348211512694217
   PubMed Web of Science ®Google Scholar
• KerrOAKavanaghGHornHAllergic contact dermatitis from topical diclofenac in Solaraze gelContact Dermatitis200247317512492560
   PubMed Web of Science ®Google Scholar
• UedaKHigashiNKumeAIkushima-FujimotoMOgiwaraSAllergic contact dermatitis due to diclofenac and indomethacinContact Dermatitis19983963239874035
   PubMed Web of Science ®Google Scholar
• PatelMJUlrichCForschnerTGenetically determined susceptibility to COX-2 inhibitors: A report of exaggerated responders to diclofenac 3% gel in the treatment of actinic keratosesBr J Dermatol2007156Suppl 3576117488409
   PubMed Web of Science ®Google Scholar
• RomanoAQuaratinoDPapaGDi FonsoMArtesaniMCVenutiADelayed hypersensitivity to diclofenac: A report on two casesAnn Allergy Asthma Immunol19988143733759809503
   PubMed Web of Science ®Google Scholar
• ZimmermanJSiguenciaJTsvangEUpper gastrointestinal hemorrhage associated with cutaneous application of diclofenac gelAm J Gastroenterol19959011203220347485017
   PubMed Web of Science ®Google Scholar
• JarvisBFiggetDPTopical 3% diclofenac in 2.5% hyaluronic gel: A review of its use in patients with actinic keratosesAm J Clin Dermatol20034320321312627996
   PubMed Web of Science ®Google Scholar
• OrtonneJPQueille-RousselCDuteilL3% diclofenac in 2.5% hyaluronic acid (Solaraze) does not induce photosensitivity or phototoxicity alone or in combination with sunscreensEur J Dermatol200616438539016935795
   PubMed Web of Science ®Google Scholar
• SillerGGebauerKWelburnPKatsamasJOgbourneSMPEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: Results of a randomized, double blind, vehicle-controlled multicentre, Phase IIa studyAustralas J Dermatol2009501162219178487
   PubMed Web of Science ®Google Scholar
• UlrichMDrecollUStockflethEEmerging drugs for actinic keratosesExpert Opin Emerg Drugs201015454555520670178
   PubMed Web of Science ®Google Scholar
• SpencerJMulticenter, randomized double blind, vehicle controlled, dose ranging study to evaluate the efficacy and safety of PEP005 (ingenol mebutate) gel, 0.05%, 0.01%, and 0.015% when used to treat actinic keratoses (AK) on the headPoster 2913, presented at the 60th annual meeting of the American Academy of DermatologyNew Orleans, LAFebruary 4–8, 2011
   Google Scholar
• SchmeiderGMulticenter, open-label, dose-area escalation cohort study to evaluate the safety of PEP005 (ingenol mebutate) gel, 0.05% applied for two consecutive days to treatment areas of up to 100 cm2 in patients with actinic keratoses (AK) on the extensor (dorsal aspect) forearms(s)Poster 2915, presented at the 60th annual meeting of the American Academy of DermatologyNew Orleans, LAFebruary 4–8, 2011
   Google Scholar
• SwansonNMulticenter, randomized, parallel-group, double-blind, vehicle-controlled study to evaluate the efficacy and safety of PEP005 (ingenol mebutate) gel, 0.05% in patients with actinic keratoses (AKO on non-head locationsPoster 105, presented at the 60th annual meeting of the American Academy of DermatologyNew Orleans, LAFebruary 4–8, 2011
   Google Scholar
• SmithSRMorhennVBPiacquadioGJBilateral comparison of the 3% diclofenac gel and 5% 5-fluorouracil cream in the treatment of actinic keratosis of the face and scalpJ Drugs Dermatol20065215615916485883
   PubMedGoogle Scholar
• GebauerKShumackSCowenPSEffect of dosing frequency on the safety and efficacy of imiquimod 5% cream for the treatment of actinic keratosis of the forearms and hands: A phase II randomized placebo-controlled trialBr J Dermatol2009161489790319545297
   PubMed Web of Science ®Google Scholar
• ColomboGLChimentiSDi MatteoSCost-effectiveness analysis of topical treatments for actinic keratosis in the perspective of the Italian health care systemG Ital Dermatol Venereol2010145557358120930692
   PubMed Web of Science ®Google Scholar
• BerlinJMRigelDSDiclofenac sodium 3% gel in the treatment of actinic keratosesJ Drugs Dermatol20087766967318664159
   PubMed Web of Science ®Google Scholar